NCT07030803View on ClinicalTrials.gov

Comparative Study of the Efficacy of Treatment of Idiopathic Overactive Bladder (OAB) in Children: Oxybutynine vs. Transcutaneous Neurostimulation

NARecruitingINTERVENTIONAL
Enrollment

124

Participants

Timeline

Start Date

March 15, 2025

Primary Completion Date

March 31, 2029

Study Completion Date

March 31, 2029

Conditions
Overactive Bladder (OAB)Transcutaneous NeurostimulationPosterior Tibial Nerve Stimulation
Interventions
OTHER

Oxybutynin

oxybutynin

DEVICE

medical device Urostim

medical device used to deliver posterior tibial nerve stimulation (PTNS)

Trial Locations (1)

Unknown

RECRUITING

CHRU Amiens, Amiens

All Listed Sponsors
collaborator

University Hospital, Rouen

OTHER

lead

Centre Hospitalier Universitaire, Amiens

OTHER